Global Influenza Medication Market Size is Expected to Grow to $6536.13 Million by 2028

Global Influenza Medication Market Overview

According to Global Market Monitor, the global influenza medication market size is expected to grow to $6536.13 million by 2028.

At present, there are two types of drugs for treating influenza viruses on the market: one is amantadine and amantadine ethylamine and the other drug is neuraminidase (NA) inhibitor, such as zanamivir, oseltamivir, peramivir, etc. Influenza medication has good safety and tolerance and can be used for the prevention and treatment of influenza. NA inhibitors are currently recommended anti-flu drugs in many countries.

Asia Pacific Dominates the Market.

As the adoption of advanced and high-cost drug therapies continues to grow, treatment rates increase, and the country's preferential reimbursement policy, Europe and the Asia-Pacific markets develop rapidly. In Europe, the demand for influenza drug products is greatest, with a large share in the inosine product sector. Asia Pacific is expected to dominate the global market due to the significant contributions of developing countries. China and India are densely populated countries with the largest number of influenza patients, which makes them the main driving force for market growth in the Asia-Pacific region.

Analysis by Type

Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It works by stopping the growth and spread of the flu virus in your body. Zanamivir helps shorten the time you have flu symptoms such as nasal congestion, sore throat, cough, muscle aches, tiredness, weakness, headache, fever, and chills. Among different types, zanamivir contributes the largest market share.

Analysis by Application

Medications for adults and children referred to flu patients are usually different. The growth of the influenza drugs market is driven by the downstream demand, and factors such as rising incidence of influenza, growing elderly population, and surge in government funding for treatment are expected to boost the growth of the market during the forecast period as the economy continues to evolve. Higher quality and more affordable products will be one of the growth opportunities for this market in the future. However, the decrease in healthcare awareness in some developing countries may negatively impact the growth of the global influenza drugs market.

By Type	Zanamivir
	Oseltamivir phosphate
	Peramivir
	Others
	Zanamivir contributes the largest market share.
By Application	Adult
	Kids
By Region	North America
	Europe
	Asia Pacific
	South America
	Middle East & Africa
	Asia Pacific Dominates the Market.